Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson’s disease-associated GBA gene

被引:0
|
作者
Marco Toffoli
Xiao Chen
Fritz J. Sedlazeck
Chiao-Yin Lee
Stephen Mullin
Abigail Higgins
Sofia Koletsi
Monica Emili Garcia-Segura
Esther Sammler
Sonja W. Scholz
Anthony H. V. Schapira
Michael A. Eberle
Christos Proukakis
机构
[1] University College London,Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology
[2] Illumina Inc.,Human Genome Sequencing Center
[3] Baylor College of Medicine,Institute of Translational and Stratified Medicine
[4] University of Plymouth School of Medicine,MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences
[5] University of Dundee,Molecular and Clinical Medicine, School of Medicine
[6] University of Dundee,Neurodegenerative Diseases Research Unit
[7] National Institute of Neurological Disorders and Stroke,Department of Neurology
[8] Johns Hopkins University Medical Center,undefined
[9] Pacific Biosciences,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
GBA variants carriers are at increased risk of Parkinson’s disease (PD) and Lewy body dementia (LBD). The presence of pseudogene GBAP1 predisposes to structural variants, complicating genetic analysis. We present two methods to resolve recombinant alleles and other variants in GBA: Gauchian, a tool for short-read, whole-genome sequencing data analysis, and Oxford Nanopore sequencing after PCR enrichment. Both methods were concordant for 42 samples carrying a range of recombinants and GBAP1-related mutations, and Gauchian outperformed the GATK Best Practices pipeline. Applying Gauchian to sequencing of over 10,000 individuals shows that copy number variants (CNVs) spanning GBAP1 are relatively common in Africans. CNV frequencies in PD and LBD are similar to controls. Gains may coexist with other mutations in patients, and a modifying effect cannot be excluded. Gauchian detects more GBA variants in LBD than PD, especially severe ones. These findings highlight the importance of accurate GBA analysis in these patients.
引用
收藏
相关论文
共 50 条
  • [1] Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson's disease-associated GBA gene
    Toffoli, Marco
    Chen, Xiao
    Sedlazeck, Fritz J.
    Lee, Chiao-Yin
    Mullin, Stephen
    Higgins, Abigail
    Koletsi, Sofia
    Garcia-Segura, Monica Emili
    Sammler, Esther
    Scholz, Sonja W.
    Schapira, Anthony H. V.
    Eberle, Michael A.
    Proukakis, Christos
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [2] Long-read nanopore sequencing for cost-effective and comprehensive analysis of GBA mutations in Norwegian patients with Parkinson's disease
    Gabbert, C.
    Schaake, S.
    Luth, T.
    Klein, C.
    Aasly, J.
    Farrer, M.
    Trinh, J.
    MOVEMENT DISORDERS, 2022, 37 : S565 - S565
  • [3] Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson ' s disease
    Marano, Massimo
    Zizzo, Carmela
    Malaguti, Maria Chiara
    Bacchin, Ruggero
    Cavallieri, Francesco
    De Micco, Rosa
    Spagnolo, Francesca
    Bentivoglio, Anna Rita
    Schirinzi, Tommaso
    Bovenzi, Roberta
    Ramat, Silvia
    Erro, Roberto
    Sorrentino, Cristiano
    Sucapane, Patrizia
    Pilotto, Andrea
    Lupini, Alessandro
    Magliozzi, Alessandro
    Di Vico, Ilaria
    Carecchio, Miryam
    Bonato, Giulia
    Cilia, Roberto
    Colucci, Fabiana
    Tamma, Filippo
    Caputo, Elena
    Mostile, Giovanni
    Arabia, Gennarina
    Modugno, Nicola
    Zibetti, Maurizio
    Ceravolo, Maria Gabriella
    Tambasco, Nicola
    Cossu, Giovanni
    Valzania, Franco
    Manganotti, Paolo
    Di Lazzaro, Vincenzo
    Zappia, Mario
    Fabbrini, Giovanni
    Tinazzi, Michele
    Tessitore, Alessandro
    Duro, Giovanni
    Di Fonzo, Alessio
    PARKINSONISM & RELATED DISORDERS, 2024, 124
  • [4] Burden of variants in Parkinson's disease-associated genes in GBA mutation carriers
    Sosero, Y. L.
    Yu, E.
    Saini, P.
    Krohn, L.
    Rudakou, U.
    Ruskey, J.
    Asayesh, F.
    Estiar, M.
    Fahn, S.
    Waters, C.
    Monchi, O.
    Dauvilliers, Y.
    Espay, A.
    Dupre, N.
    Greenbaum, L.
    Rouleau, G.
    Hassin-Baer, S.
    Fon, E.
    Alcalay, R.
    Gan-Or, Z.
    MOVEMENT DISORDERS, 2020, 35 : S212 - S212
  • [5] Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort
    Graham, O. E. E.
    Pitcher, T. L.
    Liau, Y.
    Miller, A. L.
    Dalrymple-Alford, J. C.
    Anderson, T. J.
    Kennedy, M. A.
    PARKINSONISM & RELATED DISORDERS, 2020, 70 : 36 - 41
  • [6] Gene Therapy for Parkinson's Disease Associated with GBA1 Mutations
    Abeliovich, Asa
    Hefti, Franz
    Sevigny, Jeffrey
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 : S183 - S188
  • [7] Blood lysosomal activities in Parkinson's disease associated with mutations in the GBA gene
    Bezrukova, A.
    Bogdanova, D.
    Basharova, K.
    Senkevich, K.
    Miliukhinav, I.
    Zakharova, E.
    Pchelina, S.
    Usenko, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 625 - 625
  • [8] Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
    Han, Tae-Un
    Sam, Richard
    Sidransky, Ellen
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [9] A comprehensive method for GBA whole gene-sequencing with a rapid first step screening of known Gaucher Disease mutations.
    Keddache, M
    Grabowski, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 383 - 383
  • [10] Analysis of Glucocerebrosidase (GBA) Gene Mutations in Iranian Patients with Gaucher Disease
    Mozafari, Hadi
    Tghikhani, Mohammad
    Rahimi, Zohreh
    Raygani, Asad Vaisi
    Ansari, Shahla
    Khatami, Shohreh
    Alaei, Mohammad Reza
    Saghiri, Reza
    IRANIAN JOURNAL OF CHILD NEUROLOGY, 2021, 15 (03) : 139 - 151